Basics Baxter International Inc. Baxter International Inc operates in the healthcare industry. It provides renal and hospital products such as infusion systems and systems, parenteral nutrition therapies, and biosurgery products. IPO Date: January 2, 1990 Sector: Healthcare Industry: Health Care Equipment and Supplies Market Cap: $9.53B Activated in VL: True Average Daily Range Avg Daily Range: $0.49 | 0.92% Avg Daily Range (30 D): $0.25 | 1.33% Avg Daily Range (90 D): $0.32 | 1.47% Institutional Daily Volume Avg Daily Volume: 3.38M Avg Daily Volume (30 D): 7.64M Avg Daily Volume (90 D): 6.69M Trade Size Avg Trade Size (Sh.): 149 Avg Trade Size (Sh.) (30 D): 121 Avg Trade Size (Sh.) (90 D): 112 Institutional Trades Total Inst.Trades: 62,744 Avg Inst. Trade: $3.81M Avg Inst. Trade (30 D): $3.71M Avg Inst. Trade (90 D): $4.59M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 11 Market Closing Trades Avg Closing Trade: $20.19M Avg Closing Trade (30 D): $20.76M Avg Closing Trade (90 D): $22.57M Avg Closing Volume: 374.52K     News Dec 5, 2025 @ 5:30 PM Lowey Dannenberg Notifies Baxter International, In... Source: Lowey Dannenberg P.C. Dec 4, 2025 @ 10:58 PM Bragar Eagel & Squire, P.C. Reminds James Hardie a... Source: Brandon Walker, Marion Passmore Dec 3, 2025 @ 6:40 PM DEADLINE ALERT for ATYR, MLTX, BAX, JHX: Law Offic... Source: Law Offices Of Howard G. Smith Nov 28, 2025 @ 5:00 PM BAX INVESTOR ALERT: Bronstein, Gewirtz & Grossman ... Source: Bronstein, Gewirtz & Grossman Llc Nov 25, 2025 @ 5:00 PM DEADLINE ALERT for ATYR, MLTX, BAX, JHX: Law Offic... Source: Law Offices Of Howard G. Smith Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.09 $.18 Diluted EPS $-.09 $.18 Revenue $ $ 2.84B $ 2.81B Gross Profit $ $ 950M $ 991M Net Income / Loss $ $ -46M $ 91M Operating Income / Loss $ $ 172M $ 191M Cost of Revenue $ $ 1.89B $ 1.82B Net Cash Flow $ $ 40M $ -608M PE Ratio     Splits May 31, 2001:   2:1